Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Perioperative Therapy for Incidental Gallbladder Cancer (OPT-IN): A Randomized Phase II/III Trial

NCT04559139 is registered in ClinicalTrials.gov with ECOG-ACRIN Cancer Research Group as lead sponsor.

NCT NCT04559139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04559139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Perioperative Therapy for Incidental Gallbladder Cancer (OPT-IN): A Randomized Phase II/III Trial
Lead sponsor
ECOG-ACRIN Cancer Research Group
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
February 24, 2021
Completion date
June 30, 2029
Enrollment
186 (estimated)
Sites
367

Conditions

As the registry lists them; a condition with its own page is linked.

stage ii gallbladder cancer ajcc v8, stage iia gallbladder cancer ajcc v8, stage iib gallbladder cancer ajcc v8, stage iii gallbladder cancer ajcc v8, stage iiia gallbladder cancer ajcc v8, stage iiib gallbladder cancer ajcc v8